To compare the effect of Patoladi ghrita Tarpan and Jeevantyadi ghrita Tarpan in Non-proliferative diabetic retinopathy

Comparative clinical evaluation of Patoladi ghrita and Jeevantyadi ghrita Tarpan in Dwitiya Patalagata Timir (NPDR) - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054521

Enrollment

Registered

2023-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient between age group of 40 to 70 years of either sex. 2. Patients having symptoms of non-proliferative diabetic retinopathy. 3. Patients who are fit for Tarpan. 4. Pre-diagnosed non-proliferative diabetic retinopathy patients.

Exclusion criteria

Exclusion criteria: 1. Patient less than 40 years and above 70 years of age. 2. Patient with ocular manifestation due to serious systemic illness such as carcinoma, CAD (coronary artery disease), chronic renal failure, anemia and other systemic infectious diseases like tuberculosis. 3. Patient who are contraindicated for Tarpan. 4. Patients having proliferative and advanced diabetic retinopathy changes. 5. Patient with fasting blood sugar level more than 150mg/dl and post prandial blood sugar level more then 250mg/dl. 6. Patient with complications after any ophthalmic surgery like cataract surgery etc. 7. Pregnant and lactating women. 8. Patient who are already registered under some other ongoing medical research.

Design outcomes

Primary

Measure	Time frame
1) Floaters (?? ????? ????? ? ????? ???????? ? ?? ????) Number of floaters and Interference in daily routine 2) Best corrected Visual acuity using LogMAR chartTimepoint: 0, 9 weeks, 13 weeks, 18 weeks	—

Secondary

Measure	Time frame
1. Microaneurysms. 2. Intra-retinal hemorrhages (Dot & blot & superficial hemorrhages). 3. Hard & soft exudates. 4. Venous beading. 5. Intra retinal microvascular abnormalities (IRMA). Timepoint: 0, 9 weeks	—

Countries

India

Contacts

Public ContactAman Negi

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

jyotiguptania@gmail.com9997907340

Outcome results